glp ra 1 Consensus Recommendations on GLP-1 Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force | Diabetes Therapy Review Article: GLP‐1 Receptor Agonists

Matrixyl is found in more affordable commercial products

Phase 1a: First-in-Human Single Ascending Dose Study (NCT02951806) Study Title: "Safety, Tolerability, and Pharmacokinetics of Single Doses of Cagrilintide in Healthy Subjects" Status: Completed Phase: Phase 1a Enrollment: 48 healthy volunteers Study Period: 2016-2017 Location: Single center (Denmark) Design: Randomized, double-blind, placebo-controlled, single ascending dose Dose Range: 0.03-10 mg SC Primary Endpoints: Safety, tolerability, PK parameters Population: Healthy male subjects, BMI 20-28 Key Results: Pharmacokinetics: Terminal half-life 5-7 days across dose range

So, which one is right

Measurable weight loss typically starts by week three or four